Please use this identifier to cite or link to this item:
|Title:||NO- and CO-donors: An emerging class of pharmaceuticals in current medicine|
|Authors:||Mascharak, Pradip K|
|Abstract:||In recent years, two small diatomic molecules namely, nitric oxide (NO) and carbon monoxide (CO) have been shown to play key roles in human physiology. Depending on their concentration (in the nano-to-micro molar range), these two molecules exhibit distinct physiological or pathological effects. Several exogenous NO-donors have found use as medication for blood pressure control and as anti-infective agents. CO-donating compounds have shown promises in controlling tissue damage. Demand for new and efficient NO- and CO-donors for controlled delivery of these two messenger molecules to biological targets has grown over the years and the market for such drugs is expanding at a fast rate. Inorganic and bioinorganic chemists have already contributed significantly in this area. It is expected that they will play an important role in the future design and development of these drugs.|
|Appears in Collections:||IJC-A Vol.51A(01-02) [January-February 2012]|
Files in This Item:
|IJCA 51A(01-02) 99-107.pdf||349.17 kB||Adobe PDF||View/Open|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.